Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 513.00
-1.80 (-0.35%)
May 14, 2026, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 22.06 million as of May 14, 2026. Its market cap has decreased by -62.10% in one year.
Market Cap
22.06M
Enterprise Value
-4.94M
Revenue
1.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
513.00
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 22.06M, a decrease of -68.27%. That is a compound annual growth rate of -6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 22.06M | -71.92% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 476.60M |
| Geffen Residence & Renewal | 334.87M |
| Matricelf | 78.03M |
| Clal Biotechnology Industries | 53.48M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 24.31M |
| Evogene | 23.52M |
| XTL Biopharmaceuticals | 18.92M |